Literature DB >> 8429263

Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

S Dejager1, E Bruckert, M J Chapman.   

Abstract

Patients presenting combined hyperlipidemia (CHL) display an elevated risk of coronary heart disease. The atherogenic lipoprotein particles implicated in this disorder remain ill defined. We determined the qualitative and quantitative characteristics of the density distribution of low density lipoprotein (LDL) particle subspecies in nine subjects defined phenotypically as presenting CHL, and under strict dietary control. Seven CHL patients possessed familial antecedents of premature coronary heart disease; none were E2E2 homozygotes. Five LDL subspecies were isolated by density gradient ultracentrifugation in the density range 1.019-1.063 g/ml. In all patients, the LDL profile was skewed towards the dense subspecies (LDL-4, d 1.039-1.050 g/ml and LDL-5, d 1.050-1.063 g/ml), representing 47% of total LDL mass; by contrast, these subspecies accounted for only 30% of LDL mass in five normolipidemic subjects (P < 0.01). In addition, plasma LDL mass concentrations were some twofold higher in CHL patients as compared to normolipidemic subjects. The % mass of LDL-4 was positively correlated with plasma triglyceride and apoB levels. LDL-2 and LDL-3 in CHL patients were triglyceride-enriched (11.9 and 7.2%, respectively) as compared to the corresponding subspecies in normolipidemic subjects (6.6 and 3.7%, respectively; P < 0.05 in each case). LDL particle size decreased with increase in density in both groups; however, significant differences were found between corresponding LDL subspecies (LDL-1, -3, -4, and -5) in CHL patients and normolipidemic subjects, a finding suggestive of dissimilar molecular organization, despite correspondence in hydrated density. The copper-induced oxidative modification of LDL subspecies was assessed by determination of conjugated diene formation. In both groups, LDL-5 was distinct in exhibiting a marked diminution in oxidative resistance as indicated by a significant reduction (P < 0.01) in mean lag time. The oxidative susceptibility of LDL subspecies in both groups was independent of vitamin E content when expressed as the ratio vitamin E/LDL mass, although dense LDL in CHL patients tended to be deficient in this antioxidant. The diminished oxidative resistance of dense LDL subspecies could not be accounted for by enrichment in polyunsaturated fatty acids in either group. These studies suggest that in consequence of their elevated circulating concentration and diminished oxidative resistance, dense LDL subspecies represent putative atherogenic subspecies in combined hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429263

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

Review 1.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.

Authors:  A D Sniderman; J Bergeron; J Frohlich
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

3.  Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces.

Authors:  Libo Wang; Mary T Walsh; Donald M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

4.  Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.

Authors:  Ana Paula de Queiroz Mello; Isis Tande da Silva; Aline Silva Oliveira; Valéria Sutti Nunes; Dulcineia Saes Parra Abdalla; Magnus Gidlund; Nágila Raquel Teixeira Damasceno
Journal:  Lipids       Date:  2010-06-24       Impact factor: 1.880

5.  Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study.

Authors:  Jean-Claude Ansquer; Christophe Corda; Karine Le Malicot; Valerie Jessent
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

Review 6.  Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.

Authors:  Boris Hansel; Anatol Kontush; Dominique Bonnefont-Rousselot; Eric Bruckert; M John Chapman
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

7.  Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  Ron C Hoogeveen; John W Gaubatz; Wensheng Sun; Rhiannon C Dodge; Jacy R Crosby; Jennifer Jiang; David Couper; Salim S Virani; Sekar Kathiresan; Eric Boerwinkle; Christie M Ballantyne
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-20       Impact factor: 8.311

8.  Core lipid structure is a major determinant of the oxidative resistance of low density lipoprotein.

Authors:  B Schuster; R Prassl; F Nigon; M J Chapman; P Laggner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.

Authors:  D L Tribble; J J van den Berg; P A Motchnik; B N Ames; D M Lewis; A Chait; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.